Epidemiology of esophageal adenocarcinoma.

作者: Manuel Pera , Carlos Manterola , Oscar Vidal , Luis Grande

DOI: 10.1002/JSO.20357

关键词: GastroenterologyEsophagusPopulationAdenocarcinomaIncidence (epidemiology)EpidemiologyHelicobacter pyloriInternal medicineOncologyMedicineDiseaseSurvival rate

摘要: The incidence of esophageal adenocarcinoma has risen rapidly over the past 25 years in United States as well several Western European countries. This increase had been most dramatic among white males. majority these cancers arise from a background premalignant Barrett esophagus. However, less than 10% patients with were known to have esophagus previously. It is uncertain which risk factors contribute increasing adenocarcinoma, although gastroesophageal reflux disease, cigarette smoking, and obesity implicated. Whereas infection Helicobacter pylori use non-steroidal anti-inflammatory drugs are associated reduced risk, low intakes fruit, vegetables, cereal fibers seem adenocarcinoma. Presently there no evidence that strongly supports any specific strategy screen subgroup population at for

参考文章(94)
Alan J. Cameron, Alan R. Zinsmeister, David J. Ballard, J.Aidan Carney, Prevalence of columnar-lined (Barrett's) esophagus: Comparison of population-based clinical and autopsy findings Gastroenterology. ,vol. 99, pp. 918- 922 ,(1990) , 10.1016/0016-5085(90)90607-3
Drewitz Dj, Garewal Hs, Sampliner Re, The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. The American Journal of Gastroenterology. ,vol. 92, pp. 212- 215 ,(1997)
François Potet, Jean-François Fléjou, Helena Gervaz, François Paraf, Adenocarcinoma of the lower esophagus and the esophagogastric junction Seminars in Diagnostic Pathology. ,vol. 8, pp. 126- 136 ,(1991) , 10.5555/URI:PII:074025709190035T
Diana C. Farrow, Thomas L. Vaughan, Carol Sweeney, Marilie D. Gammon, Wong-Ho Chow, Harvey A. Risch, Janet L. Stanford, Philip D. Hansten, Susan T. Mayne, Janet B. Schoenberg, Heidi Rotterdam, Habibul Ahsan, A. Brian West, Robert Dubrow, Joseph F. Fraumeni, William J. Blot, Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer. Cancer Causes & Control. ,vol. 11, pp. 231- 238 ,(2000) , 10.1023/A:1008913828105
KK Cheng, L Sharp, PA McKinney, RFA Logan, CED Chilvers, P Cook-Mozaffari, A Ahmed, NE Day, None, A case-control study of oesophageal adenocarcinoma in women: a preventable disease British Journal of Cancer. ,vol. 83, pp. 127- 132 ,(2000) , 10.1054/BJOC.2000.1121
Manuel Pera, Alan J. Cameron, Victor F. Trastek, Herschel A. Carpenter, Alan R. Zinsmeister, Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction Gastroenterology. ,vol. 104, pp. 510- 513 ,(1993) , 10.1016/0016-5085(93)90420-H
Alfred I. Neugut, Marilie D. Gammon, Habibul Ahsan, Association of adenocarcinoma and squamous cell carcinoma of the esophagus with tobacco-related and other malignancies. Cancer Epidemiology, Biomarkers & Prevention. ,vol. 6, pp. 779- 782 ,(1997)
Susan T. Mayne, Stephanie A. Navarro, Diet, Obesity and Reflux in the Etiology of Adenocarcinomas of the Esophagus and Gastric Cardia in Humans Journal of Nutrition. ,vol. 132, pp. 3467- 3470 ,(2002) , 10.1093/JN/132.11.3467S
Thomas W Rice, Gregory Zuccaro, David J Adelstein, Lisa A Rybicki, Eugene H Blackstone, John R Goldblum, Esophageal Carcinoma: Depth of Tumor Invasion Is Predictive of Regional Lymph Node Status The Annals of Thoracic Surgery. ,vol. 65, pp. 787- 792 ,(1998) , 10.1016/S0003-4975(97)01387-8